-
Effects of the novel phosphodiesterase 9 inhibitor irsenontrine on CSF proteomics profile in Aβ+ and Aβ- dementia with Lewy bodies patients
Oosthoek, M., in ’t Veld, S. G. J. G., Vermunt, L., Ye, Y., van Ingen, M., Koel-Simmelink, M., Vijverberg, E. G. B., Saxena, S., Hersch, S., Irizarry, M., Sachdev, P. & Teunissen, C. E., 1 Dec 2026, In: Alzheimer's Research and Therapy. 18, 1, 139.Research output: Contribution to Journal › Article › Academic › peer-review
-
CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer’s disease patients
Oosthoek, M., Vijverberg, E. G. B., Blujdea, E. R., Veld, S. G. J. G. I., Avilés, M. P., Zsadanyi, S. R. E., Hok-A-Hin, Y. S., Visser, A., van der Flier, W. M., Barkhof, F., del Campo, M., Schut, M. C., Bejanin, A., Alcolea, D., Teunissen, C. E. & Vermunt, L., 1 Dec 2025, In: Alzheimer's Research and Therapy. 17, 1, 169.Research output: Contribution to Journal › Article › Academic › peer-review
-
Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer’s disease: a systematic review
Oosthoek, M., Vermunt, L., de Wilde, A., Bongers, B., Antwi-Berko, D., Scheltens, P., van Bokhoven, P., Vijverberg, E. G. B. & Teunissen, C. E., 1 Dec 2024, In: Alzheimer's Research and Therapy. 16, 1, 93.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
